Req. No. 759 Page 1 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
STATE OF OKLAHOMA
1st Session of the 59th Legislature (2023)
SENATE BILL 458 By: Stanley
AS INTRODUCED
An Act relating to the practice of nursing ; providing
for independent prescriptive authority of Advanced
Practice Registered Nurses who meet certain
requirements; stating application criteria;
specifying duration of authority; authorizing
supervision by Advanced Practice Registered Nurse
with independent prescriptive authority who meets
certain requirements; authorizing Oklahoma Board of
Nursing to prescribe additional qualifications;
providing for application approva l, denial,
reapplication, fees, and independent prescriptive
authority revocation; amending 59 O.S. 2021, Section
353.1, as amended by Section 6, Chap ter 288, O.S.L.
2022 (59 O.S. Supp. 2022, Section 353.1) , which
relates to definitions used in the Oklahoma Pharmacy
Act; modifying and adding definitions; amending 59
O.S. 2021, Section 353.1a, which relates to
prescriptive authority of Advanced Practice
Registered Nurses; modifyi ng prescriptive authority
of certain Advanced Practice Registered Nurses ;
amending 59 O.S. 2021, Section 567.3a, which relates
to definitions used in the Oklahoma N ursing Practice
Act; modifying and adding definitions; amending 59
O.S. 2021, Section 567.4a, which relates to
prescriptive authority; directing the Board to
promulgate certain rules; amending 59 O.S. 2021,
Section 567.5a, which relates to Advanced Practice
Registered Nurse license; providing for independent
prescriptive authority by endorsement; amending 63
O.S. 2021, Section 2-312, as amended by Section 2 ,
Chapter 184, O.S.L. 2022 (63 O.S. Supp. 2022, Section
2-312), which relates to controlled dangerous
substances; authorizing Certified Nurse Practitioner
or Clinical Nurse Specialist to prescribe and
administer certain controlled dangerous substances;
Req. No. 759 Page 2 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
providing for codification; and providing an
effective date.
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
SECTION 1. NEW LAW A new section of law to be codified
in the Oklahoma Statutes as Section 567.4c of Title 59, unless there
is created a duplication in numbering, reads as follow s:
A. 1. An Advanced Practice Registered Nurse recognized by the
Oklahoma Board of Nursing as a Certified Nurse Practition er or
Clinical Nurse Specialist who has completed a minimum of two
thousand (2,000) hours of practice with prescriptive authority
supervised by a physician or a supervising Advanced Practice
Registered Nurse may apply to the Oklahoma Board of Nursing for
authority to prescribe and order independent of supervision.
2. The application for independent prescriptive authori ty shall
include proof that the Certified Nurse Practitioner or Clinical
Nurse Specialist:
a. has satisfied the educational requirements stated in
Section 567.5a of Title 59 of the Oklahoma Statutes,
b. has successfully passed a national certification
examination recognized by the Board that measures the
Advanced Practice Registered Nurse role and specialty
competencies,
Req. No. 759 Page 3 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
c. holds a valid, current license in the appropriate
Advanced Practice Registered Nurse role issued by the
Board and is in good standing with the Board , and
d. has completed a minimum of two thousand (2,000) hours
of practice with prescriptive authority supervised by
a physician or supervising Advanced Practice
Registered Nurse.
3. Independent prescriptive authority granted under this
subsection shall be valid until the expiration of the cu rrent
license to practice and may be r enewed upon application to the Board
at the same time and for the same period as the renewal of the
license to practice.
B. 1. A Certified Nurse Practitioner or Clinical Nurse
Specialist who has obtained independent prescriptive authority under
subsection A of this section and who has completed a minimum of
eight thousand (8,000) hours of practice with independent
prescriptive authority may serve as a supervising Advanced Practice
Registered Nurse.
2. Notwithstanding paragraph 1 of this subsection, an Advanced
Practice Registered Nurse who has been licensed and in practice for
a minimum of five (5) years as of the effective date of this act
without a lapse of work , upon obtainment of independent prescri ptive
authority under subsection A of this section , may serve as a
supervising Advanced Practice Registered Nurse.
Req. No. 759 Page 4 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
3. The Board may at its discretion prescribe by rule additional
qualifications for supervising Advanced Practice Registered Nurses
including, but not limited to, qualifications pertaining to the
Advanced Practice Registered Nurse role or specialty.
C. The Board shall review any application submitted under this
section and shall approve or deny the application, stati ng the
reason or reasons for denial, if denied. The Board shall mail the
approval or denial letter to the applicant within fourteen (14)
calendar days of receip t of the application. If denied, the
applicant may reapply using the process prescribed by subsection A
of this section.
D. The Board may suspend or revoke independent prescriptive
authority granted under this section for good cause at any time.
E. The Board may establish a fe e for the review of initial and
renewal applications under the provisions of this section.
SECTION 2. AMENDATORY 59 O.S. 2021 , Section 353.1, as
amended by Section 6, Chap ter 288, O.S.L. 2022 (59 O.S. Supp. 2022,
Section 353.1), is amended to r ead as follows:
Section 353.1. For the purposes of the Ok lahoma Pharmacy Act:
1. “Accredited program” means those seminars, classes,
meetings, work projects, and oth er educational courses approved by
the Board State Board of Pharmacy for purposes of continuing
professional education;
2. “Act” means the Oklahoma Pharmacy Act;
Req. No. 759 Page 5 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
3. “Administer” means the direct application of a drug, whethe r
by injection, inhalation, ingestion or any other means, to the body
of a patient;
4. “Assistant pharmacist” means any person presently licensed
as an assistant pharmacist in the State of Oklahom a by the Board
pursuant to Section 353.10 of this title and for the purposes of the
Oklahoma Pharmacy Act shal l be considered the same as a pharmacist,
except where otherwise specified;
5. “Board” or “State Board” means the State Board of Pharmacy;
6. “Certify” or “certification of a prescription ” means the
review of a filled prescription by a licensed pharmac ist or a
licensed practitioner with dispensing authority to confirm that the
medication, labeling an d packaging of the filled prescription are
accurate and meet all requirements prescribed by state and feder al
law. For the purposes of this paragraph, “licensed practitioner”
shall not include optometrists with dispensing authority;
7. “Chemical” means any medicinal substance, whether simple or
compound or obtained through the process of the science and art o f
chemistry, whether of organic or inorganic ori gin;
8. “Compounding” means the combining, admixing, mixing,
diluting, pooling, reconstituting or ot herwise altering of a drug or
bulk drug substance to create a drug. Compounding includes the
preparation of drugs or devices in anticipation of prescript ion drug
orders based on routine, regularly observed prescribing patterns;
Req. No. 759 Page 6 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
9. “Continuing professiona l education” means professional,
pharmaceutical education in the general areas of the socioeconomic
and legal aspects of health care; the properties and actions of
drugs and dosage forms; and the etiology, characteristics and
therapeutics of the diseased s tate;
10. “Dangerous drug”, “legend drug”, “prescription drug” or “Rx
Only” means a drug:
a. for human use subject to 21 U.S.C. 353(b)(1), or
b. is labeled “Prescription Only”, or labeled with the
following statement: “Caution: Federal law restricts
this drug except for use by or on the order of a
licensed veterinarian.”;
11. “Director” means the Executive Director of the State Board
of Pharmacy unless context clearly indicates otherwise;
12. “Dispense” or “dispensing” means the interpretation,
evaluation, and implementation of a prescription drug o rder
including the preparation and delivery of a drug or de vice to a
patient or a patient ’s agent in a suitable container appropria tely
labeled for subsequent administration to, or use by, a patient .
Dispense includes sell, distribute, leave with, give aw ay, dispose
of, deliver or supply;
13. “Dispenser” means a retail pharmacy, hospital pharmacy, a
group of chain pharmacies under c ommon ownership and control that do
not act as a wholesale distributor, or any other person authorized
Req. No. 759 Page 7 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
by law to dispense or administer prescription drugs, and the
affiliated warehouse s or distributions of such entities und er common
ownership and control t hat do not act as a wholesale distributor.
For the purposes of this parag raph, “dispenser” does not mean a
person who dispenses only products to be used in animals in
accordance with 21 U.S.C. 360b(a)(5);
14. “Distribute” or “distribution” means the sale, purchase,
trade, delivery, handling, storage, or receipt of a product, and
does not include the dispensing of a product pur suant to a
prescription executed in accordance with 21 U.S. C. 353(b)(1) or the
dispensing of a product approved under 21 U.S.C. 360 b(b); provided,
taking actual physical possession of a product or title s hall not be
required;
15. “Doctor of Pharmacy” means a person licensed by the Board
to engage in the practice of pharmacy. The terms “pharmacist”,
“D.Ph.”, and “Doctor of Pharmacy” shall be interchangeable and shall
have the same meaning wherever they a ppear in the Oklahoma Statutes
and the rules promulga ted by the Board;
16. “Drug outlet” means all manufacturer s, repackagers,
outsourcing faciliti es, wholesale distributors, third-party
logistics providers, pharmacies, and all other facilities which are
engaged in dispensing, delivery, distribution or stor age of
dangerous drugs;
Req. No. 759 Page 8 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
17. “Drugs” means all medicinal su bstances and preparations
recognized by the United States Pharmacopoeia and National
Formulary, or any revision thereof, and all substances an d
preparations intended for external and/or internal us e in the cure,
diagnosis, mitigation, treatment or preventi on of disease in humans
or animals and all substances and preparations, other than food,
intended to affect the structure or any function of t he body of a
human or animals;
18. “Drug sample” means a unit of a prescription drug packaged
under the authority and responsibility of the manufac turer that is
not intended to be sold and is intended to promote the sale of the
drug;
19. “Durable medical equipment” has the same meaning as
provided by Section 2 of this act;
20. “Filled prescription” means a packaged prescription
medication to which a label has been affixed which contain s such
information as is required by the Oklahoma Pharmacy Act;
21. “Hospital” means any institution licensed as a hospital by
this state for the care and treatment of patients, or a pharmacy
operated by the Oklahoma Department of Vet erans Affairs;
22. “Licensed practitioner” means:
a. an allopathic physician,
b. an osteopathic physician,
c. a podiatric physician,
Req. No. 759 Page 9 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
d. a dentist,
e. a veterinarian or,
f. an optometrist, or
g. a Certified Nurse Practitioner or Clinical Nurse
Specialist who has obtained independent prescriptive
authority under Section 1 of this act,
licensed to practice and authorized to prescribe dangerous drugs
within the scope of practice of such p ractitioner;
23. “Manufacturer” or “virtual manufacturer” means with respect
to a product:
a. a person that holds an application appr oved under 21
U.S.C. 355 or a license issued under 42 U.S.C. 262 for
such product, or if such product is not the subject of
an approved application or license, the person who
manufactured the pro duct,
b. a co-licensed partner of the person described in
subparagraph a that obtains the product directly from
a person described in this subpa ragraph or
subparagraph a of this paragraph,
c. an affiliate of a person described in subpara graph a
or b who receives the product directly from a person
described in this subparagraph or in subparagraph a or
b of this paragraph, or
Req. No. 759 Page 10 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
d. a person who contracts with another to manufacture a
product;
24. “Manufacturing” means the production, preparation,
propagation, compounding, conversion or processing of a device or a
drug, either directly or indirectly by extraction from substances of
natural origin or independently by means of chemic al or biological
synthesis and includes any packaging or repackaging of the
substances or labeling or relabeling of its container, and the
promotion and marketing of such drug s or devices. The term
“manufacturing” also includes the preparation and promoti on of
commercially available pro ducts from bulk compounds for resale by
licensed pharmacies, licensed practitioners or other persons;
25. “Medical gas” means those gases including those in liquid
state upon which the manufacturer or distributor has placed one of
several cautions, such a s “Rx Only”, in compliance with federal l aw;
26. “Medical gas order” means an order for medical gas issued
by a licensed prescriber;
27. “Medical gas distributor ” means a person licensed to
distribute, transfer, wholesale, deliver or sell medical gases o n
drug orders to suppliers or oth er entities licensed to use,
administer or distribute medical gas and may also include a patient
or ultimate user;
28. “Medical gas supplier” means a person who di spenses medical
gases on drug orders only to a patient or ultimate user;
Req. No. 759 Page 11 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
29. “Medicine” means any drug or combination of drugs which has
the property of curing, preventing, treating , diagnosing or
mitigating diseases, or which is used for that purpose;
30. “Nonprescription drugs ” means medicines or drug s which are
sold without a prescription and which are prepackaged for use by the
consumer and labeled in accordance with the req uirements of the
statutes and regulati ons of this state and the federal gov ernment.
Such items shall also include medical and d ental supplies and
bottled or nonbulk chemicals which are sold or offered for sale to
the general public if such articles or pre parations meet the
requirements of the Federal Food, Drug and Cosmetic Act, 21
U.S.C.A., Section 321 et seq.;
31. “Outsourcing facility” including “virtual outsourcing
facility” means a facility at one geographic location or address
that:
a. is engaged in the compounding of sterile dru gs,
b. has elected to register as an outsourcing facility,
and
c. complies with all requirem ents of 21 U.S.C. 353b;
32. “Package” means the smallest individual saleable unit of
product for distribution by a manufact urer or repackager that is
intended by the manufacturer for ultimate s ale to the dispenser of
such product. For the purposes of this paragraph, “individual
saleable unit” means the smallest container of a product introduced
Req. No. 759 Page 12 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
into commerce by the manufactur er or repackager that is intended by
the manufacturer or repackager fo r individual sale to a dispenser;
33. “Person” means an individual, partnership, limited
liability company, corporation or association, unless the context
otherwise requires;
34. “Pharmacist-in-charge” or “PIC” means the pharmacist
licensed in this state responsible for the management control of a
pharmacy and all other aspects of the practice of pharmacy in a
licensed pharmacy as defined by Section 353.18 of this title;
35. “Pharmacy” means a place regularly licensed by the Board of
Pharmacy in which prescriptions, drug s, medicines, chemicals and
poisons are compounded or dispe nsed or such place where pharmacists
practice the profession of pharmacy, or a pharmacy operated b y the
Oklahoma Department of V eterans Affairs;
36. “Pharmacy technician”, “technician”, “Rx tech”, or “tech”
means a person issued a Technician permit by the State Board of
Pharmacy to assist the pharmacist and perform nonjudgmental,
technical, manipulative, non-discretionary functions in the
prescription department under the immediate and direct super vision
of a pharmacist;
37. “Poison” means any substance which when introduced into the
body, either directly or by absorption, produces violent, morbid or
fatal changes, or wh ich destroys living tissue with which such
substance comes into contact;
Req. No. 759 Page 13 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
38. “Practice of pharmacy” means:
a. the interpretation and evaluation of prescription
orders,
b. the compounding, dispensing, administering and
labeling of drugs and devices, except labeling by a
manufacturer, repackager or distributor of
nonprescription drugs and commercially packaged legend
drugs and devices,
c. the participation in drug selection and drug
utilization reviews,
d. the proper and safe storage of drugs and de vices and
the maintenance of proper r ecords thereof,
e. the responsibility for advising by counseling and
providing information, where professionally necessary
or where regulated, of therapeutic values, content,
hazards and use of drugs and devices,
f. the offering or performing of those ac ts, services,
operations or transactions necessary in the conduct,
operation, management and control of a pharmacy, or
g. the provision of those acts or services t hat are
necessary to provide pharmaceutical care;
39. “Preparation” means an article which may or may not contain
sterile products compounded in a licensed pharmacy pursuant to the
order of a licensed prescriber;
Req. No. 759 Page 14 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
40. “Prescriber” means a person licensed in this state who is
authorized to prescribe dangerous drugs within the scope of p ractice
of the person’s profession;
41. “Prescription” means and includes any order for drug or
medical supplies written or signed, or transmitted by word of mouth,
telephone or other means of communication:
a. by a licensed prescriber,
b. under the supervision of an Oklahoma licensed
practitioner, an Oklahoma licensed advanced practice
registered nurse or an Oklahoma license d a supervising
physician, by a physician assistant or a Certified
Nurse-Midwife licensed in this state , or
c. (1) under the supervision of a supervising physician
or supervising Advanced Practice Registered
Nurse, by a Certified Nurse Practitioner or
Clinical Nurse Specialist licensed in this state
who has not obtained independent prescriptive
authority under Section 1 of this act, or
(2) by a Certified Nurse Practitioner or Clinical
Nurse Specialist licensed in this state who has
obtained independent prescriptive authority under
Section 1 of this act, or
d. by an Oklahoma licensed wholesaler or distributo r as
authorized in Section 353.29.1 of this title;
Req. No. 759 Page 15 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
42. “Product” means a prescription drug in a finished dosage
form for administration to a patient w ithout substantial further
manufacturing, such as capsules, tablets, and lyophilized products
before reconstitution. “Product” does not include blo od components
intended for transfusion, radioactive drugs or biologics and med ical
gas;
43. “Repackager”, including “virtual repackager”, means a
person who owns or operates an establishment that repac ks and
relabels a product or package for further sale or distribution
without further transaction;
44. “Sterile drug” means a drug that is intended for p arenteral
administration, an ophthalmic or oral inhalati on drug in aqueous
format, or a drug that is required to be sterile under state and
federal law;
45. “Supervising Advanced Practice Registered Nurse” has the
same meaning as provided by S ection 567.3a of this title;
46. “Supervising physician ” means an individual holding a
current license to practice as a physician from the State Board of
Medical Licensure and Supervision, pursuant to the provisions of the
Oklahoma Allopathic Medical and Surgical Licensur e and Supervision
Act, or the State Board of Osteop athic Examiners, pursuant to t he
provisions of the Oklahoma Osteopathic Medicine Act, who supervises
an advanced practice registered nurse:
Req. No. 759 Page 16 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
a. a Certified Nurse Practitioner or Clinical Nurse
Specialist as defined in Section 567.3a of this title
who has not obtained independent prescriptive
authority under Section 1 of this act, or
b. a Certified Nurse-Midwife as defined in Section 567.3a
of this title,
and who is not in trai ning as an intern, resident, or fellow . To be
eligible to supervise an advanced practice registered nurse, such
The supervising physician shall remain in compliance with the rules
promulgated by the State Board of Medical Li censure and Supervision
or the State Board of O steopathic Examiners;
46. 47. “Supportive personnel ” means technicians and auxiliary
supportive persons who are regularly paid employees of a pharma cy
who work and perform ta sks in the pharmacy as authorized by Section
353.18A of this title;
47. 48. “Third-party logistics provider” including “virtual
third-party logistics provider” means an entity that provides or
coordinates warehousing, or other logi stics services of a product in
interstate commerce on beh alf of a manufacturer, wholesale
distributor, or dispenser of a produc t but does not take ownership
of the product, nor h ave responsibility to direct the sale or
disposition of the product. For the purposes of this paragraph,
“third-party logistics provid er” does not include shippers and the
United States Postal Service;
Req. No. 759 Page 17 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
48. 49. “Wholesale distributor ” including “virtual wholesale
distributor” means a person other than a manufacturer, a
manufacturer’s co-licensed partner, a thir d-party logistics
provider, or repackager engaged in wholesale distribution as defined
by 21 U.S.C. 353(e)(4) as amended by the Drug Supply Chain Se curity
Act;
49. 50. “County jail” means a facility operated by a county for
the physical detention and correct ion of persons charged with, or
convicted of, criminal o ffenses or ordinance violations or per sons
found guilty of civil or criminal contempt;
50. 51. “State correctional facility ” means a facility or
institution that houses a p risoner population under the j urisdiction
of the Department of Corrections;
51. 52. “Unit dose package” means a package that contains a
single dose drug with the name, str ength, control number, and
expiration date of that drug on the label; and
52. 53. “Unit of issue package” means a package that provides
multiple doses of the same drug, but each drug is individually
separated and includes the name, lot number, and expirat ion date.
SECTION 3. AMENDATORY 59 O.S. 20 21, Section 353.1a, is
amended to read as f ollows:
Section 353.1a. A. Prescribing 1. Prescriptive authority
shall be allowed, under th e medical direction of a supervising
physician or supervising Advanced Practice R egistered Nurse, for an
Req. No. 759 Page 18 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
advanced practice nurse a licensed Advanced Practice Registered
Nurse recognized by the Oklahom a Board of Nursing in one of the
following categories: advanced registered nurse practitioners,
clinical nurse specialists, or certified nurse -midwives as a
Certified Nurse Practitioner or Clinical Nurse Specialist who has
not obtained independent prescriptive authority under Section 1 of
this act.
2. Prescriptive authority shall be allowed, independent of the
medical direction of a supervising physician or supervising Advanced
Practice Registered Nurse, for a licensed Advanced Practice
Registered Nurse recognized by the Oklahoma Board of Nursing as a
Certified Nurse Practitioner or Clinical Nurse Specialist who has
obtained independent prescriptive authority under Section 1 of this
act.
B. Prescriptive authority shall be allowed , under the medical
direction of a supervising physician , for a licensed Advanced
Practice Registered Nurse recognized by the Oklahoma Board of
Nursing as a Certified Nurse Practitioner.
C. The advanced practice nurse Advanced Practice Registere d
Nurse may write or sign, or transmit by word of mouth, telephone or
other means of communication an order for drugs or medical supplie s
that is intended to be filled, compounded, or dis pensed by a
pharmacist. The supervising physician or supervising Advanced
Practice Registered Nurse, if applicable, and the advanced practice
Req. No. 759 Page 19 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
nurse prescribing Advanced Practice Registered Nurse shall be
identified at the time of origination of the prescription and the
name of the advanced practice nurse prescribing Advanced Practice
Registered Nurse shall be printed on the prescription label.
B. D. Pharmacists may dispense prescriptions for non-controlled
prescription drugs authorized by an advanced practice nurse Advanced
Practice Registered Nurse or physician assistant, not located in
Oklahoma this state, provided that they are licensed in the state in
which they are actively prescribing.
C. E. 1. Pharmacists may only dispense prescriptions for
controlled dangerous substances prescribed by an advanced practice
nurse or physician assistant Advanced Practice Registered Nurse
licensed in the State of Oklahoma and supervised by an Oklahoma-
licensed practitioner this state who meets the criteria in paragraph
1 or 2 of subsection A of this section or who meets the criteria in
subsection B of this section.
2. Pharmacists may only dis pense prescriptions for contro lled
dangerous substances prescribed by a physician assistant licensed in
this state and supervised by a supervising physician licensed in
this state.
SECTION 4. AMENDATORY 59 O.S. 2021, Section 567.3a, is
amended to read as follows:
Section 567.3a. As used in the Oklahoma Nursing Practice Act:
1. “Board” means the Oklahoma Board of Nursing;
Req. No. 759 Page 20 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
2. “The practice of nursing ” means the performance of services
provided for purposes of nursing diagnosis and treatment of human
responses to actual or potential health problems consistent wit h
educational preparation. Knowledge and skill are the basis fo r
assessment, analysis, planning, intervention, and evaluation used in
the promotion and maintenance of healt h and nursing management of
illness, injury, infirmity, restoration or optimal func tion, or
death with dignity. Practice is based on understanding the human
condition across the human lifespan and understanding the
relationship of the individual within th e environment. This
practice includes execution of the medical regime including th e
administration of medications and treatments prescribed by any
person authorized by state law to so prescribe;
3. “Registered nursing” means the practice of the full scop e of
nursing which includes, but is not limited to:
a. assessing the health status of individuals, families
and groups,
b. analyzing assessment dat a to determine nursing care
needs,
c. establishing goals to meet identified health care
needs,
d. planning a strategy of care,
e. establishing priorities of nursing intervention to
implement the strategy of care,
Req. No. 759 Page 21 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
f. implementing the strategy of care,
g. delegating such tasks as may safely be performed by
others, consistent with educational preparation and
that do not conflict with the p rovisions of the
Oklahoma Nursing Practice Act,
h. providing safe and effective nursing care rendered
directly or indirectl y,
i. evaluating responses to interventions,
j. teaching the principles and practice of nursing,
k. managing and supervising the prac tice of nursing,
l. collaborating with other health profess ionals in the
management of health care,
m. performing additiona l nursing functions in accordance
with knowledge and skills acquired beyond basic
nursing preparation, and
n. delegating those nursin g tasks as defined in the rules
of the Board that may be pe rformed by an advanced
unlicensed assistive person;
4. “Licensed practical nursing” means the practice of nursing
under the supervision or direction of a registered nurse, licensed
physician or dentist. This directed scope of nursing practice
includes, but is not limited to:
a. contributing to the assessment of the h ealth status of
individuals and groups,
Req. No. 759 Page 22 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
b. participating in the development and modification of
the plan of care,
c. implementing the appropriate aspects of the plan of
care,
d. delegating such tasks as may safely be performed by
others, consistent with ed ucational preparation and
that do not conflict with the Oklahoma Nursing
Practice Act,
e. providing safe and effective nursing care r endered
directly or indirectly,
f. participating in the eva luation of responses to
interventions,
g. teaching basic nursing skills and related principles,
h. performing additional nursing procedures in accordance
with knowledge and skills acquired through education
beyond nursing preparation, and
i. delegating those nursing tasks as defined in the rules
of the Board that may b e performed by an advanced
unlicensed assistive per son;
5. “Advanced Practice Registered Nurse ” means a licensed
Registered Nurse:
a. who has completed an advanced practice registered
nursing education program in preparation for one of
Req. No. 759 Page 23 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
four recognized advanced practice registered nurse
Advanced Practice Registered Nurse roles,
b. who has passed a national certif ication examination
recognized by the Board that measures the advanced
practice registered nurse Advanced Practice Registered
Nurse role and specialty competencies and who
maintains recertification in the role and specialty
through a national certification program,
c. who has acquired adv anced clinical knowledge and
skills in preparation for providing both direct and
indirect care to patients; howeve r, the defining
factor for all Advanced Practice Re gistered Nurses is
that a significant component of the edu cation and
practice focuses on di rect care of individuals,
d. whose practice builds on the competencies of
Registered Nurses by demonstrating a gre ater depth and
breadth of knowledge, a greater synt hesis of data, and
increased complexity of skills and inte rventions, and
e. who has obtained a license as an Advanced Practice
Registered Nurse in one of the following roles:
Certified Registered Nurse An esthetist, Certified
Nurse-Midwife, Clinical Nurse Specialist, or Certified
Nurse Practitioner.
Req. No. 759 Page 24 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
Only those persons who hold a license to pract ice advanced
practice registered nursing in this s tate shall have the right to
use the title “Advanced Practice Re gistered Nurse” and to use the
abbreviation “APRN”. Only those persons who have obtained a license
in the following disciplines shall have th e right to fulfill the
roles and use the applicabl e titles: Certified Registered Nurse
Anesthetist and the abbrev iation “CRNA”, Certified Nurse-Midwife and
the abbreviation “CNM”, Clinical Nurse Specialist and the
abbreviation “CNS”, and Certified Nurse P ractitioner and the
abbreviation “CNP”.
It shall be unlawful for any person to assume the role or use
the title Advanced Practice Registered Nurse or use the abbrevi ation
“APRN” or use the respective specialty role titles a nd abbreviations
or to use any other titles or abbreviations that would reasonably
lead a person to believe the user is an Advanced Practice Regist ered
Nurse, unless permitted by the Oklahoma Nursin g Practice Act. Any
individual doing so shall be guilty o f a misdemeanor, which shall be
punishable, upon conviction, by imprisonment in the county jail for
not more than one (1) year or by a fine of not less than One Hundred
Dollars ($100.00) nor more th an One Thousand Dollars ($1,000.00), or
by both such imprisonment and fine for each offense ;
6. “Certified Nurse Practitioner” is means an Advanced Practice
Registered Nurse who performs in an expanded ro le in the delivery of
health care:
Req. No. 759 Page 25 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
a. consistent with advanced educational preparation as a
Certified Nurse Practitioner in an area of special ty,
b. functions within the Certified Nurse Practi tioner
scope of practice for the selected area of
specialization, and
c. is in accord with the standards for Certif ied Nurse
Practitioners as identified by the certifying bo dy and
approved by the Board.
A Certified Nurse Practitioner shall be eligible, in accordance
with the scope of practice of the Certified Nurse Pra ctitioner, to
obtain recognition as authorized by t he Board to prescribe, as
defined by the rules promulgated by the Board pursuant to this
section and subject to the medical direction of a su pervising
physician Section 567.4a of this title and Section 1 of this act.
This authorization shall not include d ispensing drugs, but shall not
preclude, subject to federa l regulations, the receipt of, th e
signing for, or the dispensing of professional s amples to patients.
The Certified Nurse Practitioner accepts res ponsibility,
accountability, and obligation to prac tice in accordance with usual
and customary advanced pract ice registered nursing standards and
functions as defined by the scope of practice/ role definition
statements for the Certified Nurse Practitioner;
7. a. “Clinical Nurse Specialist ” is means an Advanced
Practice Registered Nurse who holds:
Req. No. 759 Page 26 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
(1) a master’s degree or higher in nursing with
clinical specialization preparation to function
in an expanded role,
(2) specialty certification from a national
certifying organization recognized by the Board,
(3) an Advanced Practice Registered Nurse license
from the Board, and
(4) any nurse holding a specialty certification as a
Clinical Nurse Specia list valid on January 1,
1994, granted by a national certifying
organization recognized by the Board, shall be
deemed to be a Clinical Nurse Specialist under
the provisions of the Oklahoma Nursing Practice
Act.
b. In the expanded role, the Clinical Nurse S pecialist
performs at an advanced practice level which shall
include, but not be limited to:
(1) practicing as an expert clinician in the
provision of direct nursing care to a selected
population of patien ts or clients in any setting,
including private pra ctice,
(2) managing the care of patients or clients with
complex nursing problems,
Req. No. 759 Page 27 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
(3) enhancing patient or client c are by integrating
the competencies of clinical practice, education,
consultation, and re search, and
(4) referring patients or clients to ot her services.
c. A Clinical Nurse Specialist in accordance with t he
scope of practice of such Clinical Nurse Special ist
shall be eligible to obtain recognition as authorized
by the Board to prescribe, as d efined by the rules
promulgated by the Board pursua nt to this section, and
subject to the medical direction of a sup ervising
physician Section 567.4a of this title and Section 1
of this act. This authorization shall not i nclude
dispensing drugs, but shall not preclude, subject to
federal regulations, the receipt of, the signing for,
or the dispensing of profes sional samples to patients.
d. The Clinical Nurse Specialist acc epts responsibility,
accountability, and obligation to practice in
accordance with usual and customary advanced practice
nursing standards and functions as defined by the
scope of practice/rol e definition statements for the
Clinical Nurse Specialist;
8. “Nurse-Midwife” is means a nurse who has received an
Advanced Practice Registered Nurs e license from the Oklahoma Board
Req. No. 759 Page 28 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
of Nursing who possesses evidence of certification according to the
requirements of the American College of Nurse -Midwives.
A Certified Nurse-Midwife in accordance with the scope of
practice of such Certified Nurse -Midwife shall be eligible to obtain
recognition as authori zed by the Board to prescribe, as defined by
the rules promulgated by the Board pursuant to this section and
subject to the medical direction of a supervising physician . This
authorization shall not inclu de the dispensing of drugs, but shall
not preclude, subject to federal regulations, the receipt of, the
signing for, or the dispensing of professional samples to patients .
The Certified Nurse-Midwife accepts responsibility ,
accountability, and obligation t o practice in accordance with usual
and customary advanced practice registered nursing standards and
functions as defined by the scope of practice/role definition
statements for the Certified Nurse-Midwife;
9. “Nurse-midwifery practice” means providing management of
care of normal newborns and women, ante partally, intrapartally,
postpartally and gynecologicall y, occurring within a health care
system which provides for med ical consultation, medical management
or referral, and is in accord with the standards for nurse-midwifery
practice as defined by the Ame rican College of Nurse -Midwives;
10. a. “Certified Registered Nurse Anesthetist ” is an
Advanced Practice Registered Nur se who:
Req. No. 759 Page 29 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
(1) is certified by the National Board of
Certification and Recertification f or Nurse
Anesthetists as a Certified Registered Nur se
Anesthetist within one (1) year following
completion of an approved certified registered
nurse anesthetist Certified Registered Nurse
Anesthetist education program, and continues to
maintain such recert ification by the National
Board of Certification an d Recertification for
Nurse Anesthetists, and
(2) administers anesthesia in collaboration with a
medical doctor, an oste opathic physician, a
podiatric physician or a dentis t licensed in this
state and under conditions in which timely onsite
consultation by such doctor, osteopath, podiatric
physician or dentist i s available.
b. A Certified Registered Nurse Anesthetist, in
collaboration with a medical doctor, osteopathic
physician, podiatric physician or dent ist licensed in
this state, and under conditions in which timely, on-
site consultation by such medical docto r, osteopathic
physician, podiatric physician or dentist is
available, shall be authorized, pursuant to rules
adopted by the Oklahoma Board of Nursi ng, to order,
Req. No. 759 Page 30 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
select, obtain and administer legend drugs, Schedules
II through, III, IV, and V controlled substances,
devices, and medical gases only when engaged in the
preanesthetic preparation and evaluation; anesthesia
induction, maintenance and emergence; and
postanesthesia care. A Certified Register ed Nurse
Anesthetist may order, select, obtain and adminis ter
drugs only during the perioperative or periobstetrical
period.
c. A Certified Registered Nurse Anesthetist who applies
for authorization to order, select, obtain and
administer drugs shall:
(1) be currently recognized as a Certified Registered
Nurse Anesthetist in this state,
(2) provide evidence of completion, wi thin the two-
year period immediately preceding the d ate of
application, of a minimum of fifteen (15) units
of continuing education in a dvanced pharmacology
related to the administration of anes thesia as
recognized by the National Board of Certification
and Recertification for Nurse Anesthetists, and
(3) complete and submit a no tarized application, on a
form prescribed by the Board, accomp anied by the
Req. No. 759 Page 31 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
application fee established pursuant to this
section.
d. The authority to order, select, obtain and administ er
drugs shall be terminated if a Certified Register ed
Nurse Anesthetist has:
(1) ordered, selected, obtained or administered drugs
outside of the Certified Registered Nurse
Anesthetist scope of practice or ordered,
selected, obtained or administered drugs for
other than therapeutic purposes, or
(2) violated any provision of st ate laws or rules or
federal laws or regulations pertaining to the
practice of nursing or the authority to order,
select, obtain and administer drugs.
e. The Oklahoma Board of Nursing shall notify the Board
of Pharmacy after terminatio n of or a change in t he
authority to order, select, obtain and administer
drugs for a Certified Registered Nurse Anesthetist.
f. The Board shall provide by rule for biennial
application renewal and reauth orization of authority
to order, select, obtain and administer drugs for
Certified Registered Nurse Anesthetists. At the time
of application renewal, a Certified Registered Nurse
Anesthetist shall submit documentation of a minimum of
Req. No. 759 Page 32 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
eight (8) units of co ntinuing education, completed
during the previous tw o (2) years, in advan ced
pharmacology relating to the administration of
anesthesia, as recognized by the Council on
Recertification of Nurse Anesthetists or the Council
on Certification of Nurse Anestheti sts.
g. This paragraph shall not prohibit the admini stration
of local or topical anesthetics as now permitted by
law. Provided further , nothing in this paragraph
shall limit the authority of t he Board of Dentistry to
establish the qualifications for denti sts who direct
the administration of anesthesia.
h. As used in this parag raph, “collaboration” means an
agreement between a medical doc tor, osteopathic
physician, podiatric physician or dentist performing
the procedure or directly involved with the procedu re
and the Certified Registered Nurse Anesthetist wo rking
jointly toward a common goal providing services for
the same patient. This c ollaboration involves the
joint formulation, discussion an d agreement of the
anesthesia plan by both parties, and the col laborating
medical doctor, osteopathic physician, po diatric
physician or dentist performing the procedure or
directly involved with the procedure and that. The
Req. No. 759 Page 33 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
collaborating physician shall re main available for
timely onsite consultation during the delive ry of
anesthesia for diagnosis, consultation, and tr eatment
of medical conditions;
11. “Supervising Advanced Practice Registered Nurse” means an
Advanced Practice Registered Nurse holding a current license to
practice who has obtained independent prescriptive authority under
Section 1 of this act and who otherwise meets the qualification s of
a supervising Advanced Practice Registered Nur se under Section 1 of
this act who supervises a Certified Nurse Practitioner or a Clinical
Nurse Specialist who has not obtained independent prescriptive
authority under Section 1 of this act ;
12. “Supervising physician” means an individual holding a
current license to practice as a physi cian from the State Board of
Medical Licensure and Supervision or the State Board of Osteopathic
Examiners, who supervises :
a. a Certified Nurse Practitioner , or a Clinical Nurse
Specialist who has not obtained independent
prescriptive authority under Section 1 of this act, or
b. a Certified Nurse-Midwife,
and who is not in training as an intern, resident, or fellow. To be
eligible to supervise such Advanced Practice Regis tered Nurse, such
The supervising physician shall remain in compliance with t he rules
Req. No. 759 Page 34 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
promulgated by the State Board of Medical Licensure and Supervision
or the State Board of Osteopathic Examiners;
12. 13. “Supervision of an Advanced Practice Registered Nurse
with prescriptive authority” means overseeing and accepting
responsibility for the ordering and transmission by:
a. a Certified Nurse Practitioner , or a Clinical Nurse
Specialist who has not obtained independent
prescriptive authority under Section 1 of this act, or
b. a Certified Nurse-Midwife,
of written, telephonic, electronic or oral prescriptions for drugs
and other medical supplies, subject to a defined fo rmulary; and
13. 14. “Advanced Unlicensed Assistant ” means any person who
has successfully completed a certified training program approved by
the Board that trains the Advanced Unlicensed Assistant to perform
specified technical skills identified by the B oard in acute care
settings under the direction and supervision of the Registered Nurse
or Licensed Practical Nurse.
SECTION 5. AMENDATORY 59 O.S. 2021, Section 567.4a, is
amended to read as follows:
Section 567.4a. The Oklahoma Board of Nursing may grant
prescriptive authority through the Advanc ed Practice Registered
Nurse license to Certified Nurse Practitioners, Certified Nurse-
Midwives, and Clinical Nurse Specialists who meet the requirements
for prescriptive authority identif ied by law and in the Board’s
Req. No. 759 Page 35 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
rules. The rules regarding prescriptiv e authority recognition
promulgated by the Oklahoma Board of Nursing pursuant to paragraphs
6 through 9, 11 and 12 of Section 567.3a of this ti tle shall:
1. Define the procedure for docu menting supervision by a
supervising physician licensed in Oklahoma t o practice by the State
Board of Medical Licensure and Supervision or the State Board of
Osteopathic Examiners or a supervising Advanced Practice Registered
Nurse, if applicable. Such procedure shall i nclude a written
statement that defines appropriate referral, consultati on, and
collaboration between the Advanced Practice Registered Nurse,
recognized to prescribe as defined in paragraphs 6 through 9, 11 and
12 of Section 567.3a of this title, and the s upervising physician or
supervising Advanced Practice Registered Nurse, if applicable. The
written statement shall include a method of assuring availability of
the supervising physician or supervising Advanced Practice
Registered Nurse through direct contact, telecommun ications or other
appropriate electronic means for consul tation, assistance with
medical emergencies, or patient referral. The written statement
shall be part of the initial application and the renewal application
submitted to the Board for recognition fo r prescriptive authority
for the Advanced Practice Regist ered Nurse. Changes to the written
statement shall be filed with the Board within thirty (30) day s of
the change and shall be effective on filing;
Req. No. 759 Page 36 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
2. Define the procedure for documenting independent
prescriptive authority for Certified Nurse Practitioners and
Clinical Nurse Specialists who have obtained independent
prescriptive authority unde r the Section 1 of this act;
3. Define minimal requirements for initial application for
prescriptive authority which shall in clude, but not be limited to,
evidence of completion of a minimum of forty-five (45) contact ho urs
or three (3) academic credit hours of education in
pharmacotherapeutics, clinical application, and use of
pharmacological agents in the prevention of illness , and in the
restoration and maintenance of health in a program beyond basic
registered nurse preparation, approved by the Board. Such contact
hours or academic credits shall be obtained within a time period of
three (3) years immediately preceding the da te of application for
prescriptive authority ;
3. 4. Define minimal requirements for applicatio n for renewal
of prescriptive authority which shall include, but not be limited
to, documentation of a minimum of:
a. fifteen (15) contact hours or one (1) acade mic credit
hour of education in pharmacother apeutics, clinical
application, and use of pharmaco logical agents in the
prevention of illness, and in the rest oration and
maintenance of health in a program beyond basic
registered nurse preparation, and
Req. No. 759 Page 37 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
b. two (2) hours of education in pain management or two
(2) hours of education in opioid use or addict ion,
unless the Advanced Practice Registered Nurse has
demonstrated to the satisfaction of the Board that the
Advanced Practice Registered Nurse does not current ly
hold a valid federal Drug Enforcement Adm inistration
registration number,
approved by the Board, within the two-year period immediately
preceding the effective date of application for renewal of
prescriptive authority;
4. 5. Require that beginning July 1, 2002, an Advanced Practice
Registered Nurse shall demonstrate demonstrates successful
completion of a master’s degree or higher in a clinical nurse
specialty one of the four Advanced Practice Registered Nurs e roles
in order to be eligible for initial application fo r prescriptive
authority under the provisions of the Oklahoma Nursing Practice Act;
5. 6. Require an Advanced Practice Registered Nurse to have
graduated from a program accredited by the Accredita tion Commission
for Education in Nursing (ACEN) or the Commission on Collegiate
Nursing Education (CCNE), or a substantially equivalent program
approved by the Board in order to be eligible for initial
application for prescriptive authority under the provi sions of the
Oklahoma Nursing Practice Act . As a condition of obtaining
prescriptive authority, an Advanced Practice Registered Nurse shall
Req. No. 759 Page 38 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
show evidence of annual on -campus attendance for assessment and
evaluation of student progress and competence in ad dition to
completing the required clinical hours in the graduate program
consistent with the national standard;
7. Define the method for communicating authority to pr escribe
or termination of same, an d the formulary to the Board of Pharmacy,
all pharmacies, and all registered pharmacists;
6. 8. Define terminology used in such rules;
7. 9. Define the parameters for the prescribing practices of
the Advanced Practice Re gistered Nurse;
8. 10. Define the methods for termination of prescriptive
authority for the Advanced Practice Registered Nurse; and
9. 11. a. Establish a Formulary Advisory Coun cil that shall
develop and submit to the Board recommendations for an
exclusionary formulary that shall list drugs or
categories of drugs that shall not be prescribed by
Advanced Practice Registered Nurse recognized to
prescribe by the Oklahoma Board of Nu rsing. The
Formulary Advisory Council shall also develop and
submit to the Board recommendations for practice-
specific prescriptive standards for each category of
Advanced Practice Registered Nurse recognized to
prescribe by the Oklahoma Board of Nursing pursuant to
the provisions of the Oklahoma Nursing Practice Act.
Req. No. 759 Page 39 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
The Board shall either accept or reject the
recommendations made by the Council. No amendments to
the recommended exclusionary formulary may be made by
the Board without the approval of the Formulary
Advisory Council.
b. The Formulary Advisory Council shall be compos ed of
twelve (12) members as follo ws:
(1) four members, to include a pediatrician, an
obstetrician-gynecological physician, a general
internist, and a family practice physician;
provided that three of such members shall be
appointed by the Oklahoma State M edical
Association, and one shall be appointed by the
Oklahoma Osteopathic Association,
(2) four members who are registered pharmacists,
appointed by the Oklahoma Pharmaceutical
Association, and
(3) four members, one of whom shall be a Certified
Nurse Practitioner, one of whom shall be a
Clinical Nurse Specialist, one of whom shall be a
Certified Nurse-Midwife, and one of whom shall be
a current member of the Oklahoma Board of
Nursing, all of whom shall be appointed by the
Oklahoma Board of Nursing.
Req. No. 759 Page 40 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
c. All professional members of the Formul ary Advisory
Council shall be in active clinical practi ce, at least
fifty percent (50%) of the time, withi n their defined
area of specialty. Th e members of the Formulary
Advisory Council shall serve at the pleasure of the
appointing authority for a term o f three (3) years.
The terms of the members shall be s taggered. Members
of the Council may serve beyond the expiration of
their term of office until a successor is appointed by
the original appointing authority. A vacan cy on the
Council shall be filled for the balance of the
unexpired term by the original a ppointing authority.
d. Members of the Council shal l elect a chair and a vice -
chair from among the membership of the Council. For
the transaction of business, at leas t seven members,
with a minimum of two members present from each of the
identified categories of physicians, pharmacists and
advanced practice registered nurses Advanced Practice
Registered Nurses, shall constitute a quorum. The
Council shall recommend an d the Board shall approve
and implement an initial exclusionary formulary on or
before January 1, 1997. The Council and the Board
shall annually review the approved exclusionary
formulary and shall make any necessary revisions
Req. No. 759 Page 41 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
utilizing the same procedure s used to develop the
initial exclusionary formulary.
SECTION 6. AMENDATORY 59 O.S. 2021, Section 567.5a, is
amended to read as fo llows:
Section 567.5a. A. All applicants for a license to practice a s
an Advanced Practice Registered Nurse shall be subject to Section
567.8 of this title.
B. An applicant for an initial license to practice as an
Advanced Practice Registered Nurse shal l:
1. Submit a completed written application and appropriate fees
as established by the Board;
2. Submit a criminal history records check that compl ies with
Section 567.18 of this title;
3. Hold a current Registered Nurse license in this state;
4. Have completed an advanced practice registered nursing
education program in one of the four advanced practice regi stered
nurse Advanced Practice Registere d Nurse roles and a specialty area
recognized by the Board. Effective January 1, 2016, the applic ant
shall have completed an ac credited graduate level advanced practice
registered nursing education program in at lea st one of the
following population foci: family/individual across the lifespan,
adult-gerontology, neonatal, pediatrics, women ’s health/gender-
related, or psychiatric/ mental health;
Req. No. 759 Page 42 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
5. Be currently certified in an advanced practice specialty
certification consistent with educational preparatio n and by a
national certifying body recognized by the Board; and
6. Provide any and all other evi dence as required by the Board
in its rules.
C. The Board may issue a license by endorsement to an Advanced
Practice Registered Nurse licensed under the laws of another state
if the applicant meets the qualifications for licensure in this
state. An applicant by endorsement shall:
1. Submit a completed written application and appr opriate fees
as established by the Board ;
2. Hold a current Registered Nurse li cense in this state;
3. Hold recognition as an Advanced Practice Registered Nurse in
a state or territory;
4. Have completed a n advanced practice registered nursing
education program in one of the four roles and a specialty area
recognized by the Board. Effective January 1, 2016, the applicant
shall have completed an accredited graduate level advanc ed practice
registered nursing education program in at least one of the
following population foci: family/individual across the lifespan,
adult-gerontology, neonatal, pediatrics, women’s health/gender-
related, or psychiatric/mental health;
Req. No. 759 Page 43 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
5. Be currently certified in an advanced pra ctice specialty
certification consistent with ed ucational preparation and by a
national certifying body recognized by the Board;
6. Meet continued competency requirements as set forth in Board
rules; and
7. Provide any and a ll other evidence as required by the Board
in its rules.
D. The Board may iss ue prescriptive authority recognition by
endorsement to an Advanced Practice Reg istered Nurse licensed as an
APRN-CNP, APRN-CNS, or APRN-CNM under the laws of another state if
the applicant meets the requirem ents set forth in this section. An
applicant for prescriptive authority recognition by endorsement
shall:
1. Submit a complete d written application and appropriate fees
as established by the Board;
2. Hold current Registere d Nurse and Advanced Practice
Registered Nurse licenses (APRN-CNP, APRN-CNS, or APRN-CNM) in the
state;
3. Hold current licensure or recognition as an Advanc ed
Practice Registered Nurse in the same role and specialty with
prescribing privileges in another state or territory;
4. Submit documentation verifying successful completion of a
graduate level advanced practice re gistered nursing education
program that included an academic course in pharmacotherapeutic
Req. No. 759 Page 44 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
management, and didactic and clinical preparati on for prescribing
incorporated throughout the program;
5. Submit:
a. a written statement from an Oklahoma licensed
physician or supervising Advanced Practice Registered
Nurse supervising prescriptive authority as required
by the Board in its rules , if the applicant is a
Certified Nurse Practitioner or Clinical Nurse
Specialist,
b. a written statement from an Oklahoma licensed
physician supervising prescriptive authority as
required by the Board in its rules , if the applicant
is a Certified Nurse -Midwife, or
c. submit documentation that the applicant meets the
requirements for independ ent prescriptive authority
under Section 1 of this act;
6. Meet continued competency requirements as set forth in Board
rules; and
7. Provide any and all other evide nce as required by the Board
in its rules.
E. An Advanced Practice Registered Nurs e license issued under
this section shall be renewed concurrently with the regis tered nurse
license provided that qualifying criteria c ontinue to be met.
Req. No. 759 Page 45 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
F. The Board may reinstate a license as set forth in Boa rd
rules.
SECTION 7. AMENDATORY 63 O.S. 2021, Section 2-312, as
amended by Section 2 , Chapter 184, O.S.L. 2022 (63 O.S. Supp. 2022,
Section 2-312), is amended to read a s follows:
Section 2-312. A. A physician, podiatrist, optometrist or a
dentist who has complied with the registration requirements of the
Uniform Controlled Dangerous Substan ces Act, in good faith and in
the course of such person’s professional practice only, may
prescribe and administer controlled dangerous substances, or may
cause the same to be administer ed by medical or paramedical
personnel acting under the direction and supervision of the
physician, podiatrist , optometrist or dentist, and only may d ispense
controlled dangerous substa nces pursuant to the provisions of
Sections 355.1 and 355.2 of Title 59 of the Oklahoma Statutes.
B. A veterinarian who has complied wi th the registration
requirements of the Uniform Controlled Dangerous Substances Act, in
good faith and in the cours e of the professiona l practice of the
veterinarian only, and not for use by a human being, may prescribe,
administer, and dispense controlled dangerous substances and may
cause them to be administered by an assistant or o rderly under the
direction and supervision of the veter inarian.
C. 1. An advanced practice nurse Advanced Practice Registered
Nurse who is recognized to prescribe by the Oklahoma Board of
Req. No. 759 Page 46 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
Nursing as an advanced registered nurse practitioner, clinical nurse
specialist or certified nurse-midwife, a Certified Nurse
Practitioner or Clinical Nurse Specialist but who has not obtained
independent prescriptive authority under Section 1 of this act and
therefore is subject to medical direction by a supervising
physician, or supervising Advanced Prac tice Registered Nurse
pursuant to Section 567.3a of Title 59 of the Oklahoma St atutes, and
who has complied with the re gistration requirements of the Unif orm
Controlled Dangerous Substances Act, in good faith and in the cours e
of professional practi ce only, may prescribe and administer Schedule
III, IV and V controlled dangerous subs tances.
2. An Advanced Practice Registered Nurse wh o is recognized to
prescribe by the Okla homa Board of Nursing as a Certified Nurse
Practitioner or Clinical Nurse Specialist who has obtained
independent prescriptive authority under Section 1 of this act, and
who has complied with the regis tration requirements of th e Uniform
Controlled Dangerous Subs tances Act, in good faith and in the course
of professional practice only, may prescribe and administer Schedule
III, IV, and V controlled dangerous substances.
D. An Advanced Practice Registered Nurse wh o is recognized to
prescribe by the Okla homa Board of Nursing as a Certified Nurse-
Midwife, who is subject to medical direction by a supervising
physician pursuant to Section 567.3a of Title 59 of the Oklahoma
Statutes, and who has complied with the registration requirements of
Req. No. 759 Page 47 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
the Uniform Controlled Dangerous Substances Act, in good faith and
in the course of professional practice only, may prescribe and
administer Schedule III, IV, and V controlled dangerous sub stances.
E. An advanced practice nurse Advanced Practice Register ed
Nurse who is recognized to order , select, obtain and administer
drugs by the Oklahoma Board of Nursing as a certified registered
nurse anesthetist Certified Registered Nurse Anesthetist pursuant to
Section 353.1b of Title 59 of the Oklahoma Statutes and who has
complied with the registra tion requirements of the Uniform
Controlled Dangerous Substances Act, in good faith and i n the course
of such practitioner’s professional practice only, may order,
select, obtain and administer S chedules II through, III, IV, and V
controlled dangerous subst ances in a preanesthetic preparation or
evaluation; anesthesia induction, maintenance or emergence; or
postanesthesia care setting only. A certified registered nurse
anesthetist Certified Registered Nurse Anesthetist may order,
select, obtain and administ er such drugs only during the
perioperative or periobstetrical period.
E. F. A physician assistant who is recognized to prescribe by
the State Board of Medical Licensure and Supervision under th e
medical direction of a s upervising physician, pursuant to Section
519.6 of Title 59 of the O klahoma Statutes, and who has complied
with the registration requirements of the Uniform Controlled
Dangerous Substances Act, in good faith and in the course of
Req. No. 759 Page 48 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
professional practice only, may prescribe and administe r Schedule II
through V Schedules II, III, IV, and V controlled dangerous
substances.
SECTION 8. This act shall become effective November 1, 2023.
59-1-759 DC 1/17/2023 11:08:41 AM